NCT04415697View on ClinicalTrials.gov

Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

February 20, 2020

Study Completion Date

April 10, 2020

Conditions
Kidney CancerBiomarkersGene Expression
Interventions
DIAGNOSTIC_TEST

Gene expression test using nanostring technology.

Evaluation of gene expression profile of a panel with 770 genes related to disease progression using nanostring technology

Trial Locations (1)

14784400

Andre Octavio Nicolau Sanches, Barretos

All Listed Sponsors
lead

Barretos Cancer Hospital

OTHER

NCT04415697 - Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas | Biotech Hunter | Biotech Hunter